Form 4: W. Andrew Adams Acquires 10,000 Stock Options in National Health Investors Inc.
SEC Form 4 Filing
Director W. Andrew Adams reports acquisition of 10,000 stock options in National Health Investors Inc. on February 23, 2024.
Summary
- W. Andrew Adams, a director of National Health Investors Inc. (NHI), filed a Form 4 disclosing changes in beneficial ownership.
- On February 23, 2024, Adams acquired 10,000 stock options with an exercise price of $57.76, expiring on February 23, 2029.
- Adams also directly owns 25,000 stock options from 2020, 25,000 stock options from 2021, 25,000 stock options from 2022, and 10,000 stock options from 2023.
- Adams indirectly owns 708,469 shares of common stock through a revocable living trust, 177,000 shares through the Adams Family Foundation II, and 12,635 shares through the JMA Grandchildren's Trust.
- Additionally, Adams directly owns 121,035 shares of common stock through the W. Andrew Adams Exempt Trust.
- His spouse holds 11,707 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock option acquisition and ownership.
Positives
- The acquisition of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency to investors regarding the actions of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
- The details provided are consistent with the level of information typically disclosed in such filings.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- It can influence investor perception of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 02/21/2020 | Date of Stock Options (Right to Buy) 2-21-2020 |
| 02/25/2021 | Date of Stock Options (Right to Buy) 2-25-2021 |
| 02/25/2022 | Date of Stock Options (Right to Buy) 2-25-2022 |
| 02/24/2023 | Date of Stock Options (Right to Buy) 2023 |
| 02/23/2024 | Date of Earliest Transaction and Date of Stock Option (Right to Buy) 2024 |
| 02/23/2029 | Expiration Date of Stock Option (Right to Buy) 2024 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.